Nutriband (NTRB) announced that Company founder, Gareth Sheridan has returned as Company CEO. During the period of August 10 until October 27 , Co-Founder and Chairman, Serguei Melnik had taken over the responsibilities of CEO. Mr Sheridan has returned to the position of CEO effective immediately and will guide the company through the final 2025 framework towards the target NDA filing in 2026 for AVERSA Fentanyl.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTRB:
- Nutriband signs agreement with Brand Institute to develop brand for patch
- Nutriband files provisional patent application for AVERSA technology
- Oracle surges on cloud outlook, Novo to cut 9,000 jobs: Morning Buzz
- Nutriband reports Q2 EPS ($2.12) vs. (15c) last year
- Nutriband Issues Shares Amid Investor Engagement